Publicaciones (236) Publicaciones de JUAN CARLOS LEZA CERRO

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

  2. Decreased oxytocin levels related to social cognition impairment in borderline personality disorder

    Acta Psychiatrica Scandinavica

  3. Decreased oxytocin plasma levels and oxytocin receptor expression associated with aggressive behavior in aggressive-impulsive disorders

    Journal of Psychiatric Research, Vol. 170, pp. 200-206

  4. Differential regulation of innate immune system in frontal cortex and hippocampus in a "double-hit" neurodevelopmental model in rats

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, Vol. 21, Núm. 1, pp. e00300

  5. Inflammatory profiles in women with eating disorder: Linking inflammatory biomarkers to clinical phenotypes

    Psychoneuroendocrinology, Vol. 162

  6. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  7. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation

    Psychiatry Research, Vol. 331

  8. Transdiagnostic inflammatory and oxidative biomarkers with predictive capacity of self-injurious behavior in impulsive and unstable disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 130

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  2. Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

  3. Inflammatory and oxidative endophenotypes in borderline personality disorder: A biomarker cluster analysis

    World Journal of Biological Psychiatry, Vol. 24, Núm. 7, pp. 587-594

  4. Neuroimaging Revealed Long-Lasting Glucose Metabolism Changes to Morphine Withdrawal in Rats Pretreated with the Cannabinoid Agonist CP-55,940 during Periadolescence

    European Neuropsychopharmacology, Vol. 69, pp. 60-76

  5. Neuroinflammation related to the blood–brain barrier and sphingosine-1-phosphate in a pre-clinical model of periodontal diseases and depression in rats

    Journal of Clinical Periodontology, Vol. 50, Núm. 5, pp. 642-656

  6. Oxidative stress and inflammatory pathways in female eating disorders and borderline personality disorders with emotional dysregulation as linking factors with impulsivity and trauma

    Psychoneuroendocrinology, Vol. 158

  7. Salivary secretory immunoglobulin A as a potential biomarker of psychosocial stress response during the first stages of life: A systematic review

    Frontiers in Neuroendocrinology, Vol. 71

  8. The gut-microbiota-brain axis in a Spanish population in the aftermath of the COVID-19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles

    Gut microbes, Vol. 15, Núm. 1, pp. 2162306

2022

  1. CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes

    International journal of molecular sciences, Vol. 23, Núm. 6

  2. Dysfunction of Inflammatory Pathways and Their Relationship With Psychological Factors in Adult Female Patients With Eating Disorders

    Frontiers in Pharmacology, Vol. 13

  3. Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study

    Frontiers in Pediatrics, Vol. 10

  4. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13